Producer Cell Line Development
Get the right cell line for production of your vector and virus!
Cell Lines for Viral Vector and Virus Production
Quality Drives Outcome
Across Whole Viral Vectors GMP Life Cycle
Our services comprise everything from the start of your viral vectors GMP life cycle by generation of your MCB and/or MVS either from your cell line or vector platform or out of one of our established MCBs or vectors.
GMP-Compliance
Capability and Scale
Over the expansion of the cells in scales up to 200 L and the production of your vector by either transfection, producer cell line or infection based methods. Depending on the type of virus and cells we are capable of establishing contentious harvest methods over multiple days to maximize yield.
State-of-Art Technologies
Up to the downstream purification of your product with state of the art disposable systems for dead end filtration, tangential flow filtration or chromatographic purification.
Drug Product Filling
At the end of the value chain, the drug substance is refined into a drug product. Our filling process is based on a semi-automated solution (robotic support) in a class A clean room environment. We are capable of aseptically filling the drug product and required diluents into vials with the sizes 2, 6 and 20 mL with a throughput of approx. 200 - 400 vials per hour.
All on One Place
Short distances between our production facility and the quality control laboratories ensure optimal handling and analysis of sensitive viral products and intermediates.
Hek 293 Cell Line for Unparalleled Control
At our facility, we have generated several specialized cell lines to meet diverse production needs. Most notably, our proprietary HEK293 cell line.
Our HEK293 cell line is specifically engineered for the production of lentiviruses, AAV, and adenoviruses. This cell line offers unparalleled control over the manufacturing process, ensuring consistency and quality in the final product.
Duck Cell Line for the Production of MVA and Other Vaccine Candidates
In addition to HEK293, our unique AGE1.CR.pIX® duck cell line has been developed in-house for the production of MVA and different viral vaccine strains for human and veterinary application. This cell line is optimized to enhance yield and scalability by addressing the specific requirements of these viral vectors.
Suspension Culture Systems for More Efficiency
The use of suspension culture systems further improves production efficiency by enabling higher cell densities and facilitating easier scale-up in bioreactors.
Chemically Defined Media to Eliminate Variability
The use of chemically defined media across our cell lines eliminates the variability and potential contaminants associated with serum-based media, thereby ensuring a more predictable and reproducible environment for cell growth and virus production. This not only enhances the safety profile of the produced viral vectors and viruses, it also simplifies regulatory compliance.
This approach helps us achieve a more efficient, scalable, and high-quality production process for viral vectors, which ultimately accelerates the path from research to clinical application.
Our Promise To You
High Yield in Suspension Culture
- Suspension-adapted producer cells enable scalable, high-yield production in bioreactors
- This makes them ideal for large-scale viral vector and vaccine manufacturing
Consistency with Chemically Defined Medium
- Growing producer cells in a chemically defined medium ensures a consistent and reproducible environment
- This helps control batch variability, improve process reliability, and ensure consistent viral vector potency
Enhanced Safety and Compliance with GMP Grade Suspension Lines
- Suspension-adapted, fully characterized master and working cell banks (MCBs, WCBs) in chemically defined media meet rigorous safety and regulatory standards
- This supports robust production processes in essentially closed system